QIAGEN N.V. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
QIAGEN N.V. (QGEN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$28.20 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-03-14
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2021-12-31 | -$28.20M 20-F · filed 2022-03-14 | |
| 2020-12-31 | $36.80M 20-F · filed 2021-03-05 | |
| 2019-12-31 | $19.00M 20-F · filed 2021-03-05 | |
| 2018-12-31 | $800.00K 20-F · filed 2021-03-05 | |
| 2017-12-31 | $62.30M 20-F · filed 2020-03-02 | |
| 2016-12-31 | $1.80M 20-F · filed 2019-03-06 | $0.00 20-F · filed 2017-03-06 |
| 2015-12-31 | -$300.00K 20-F · filed 2016-02-29 | |
| 2011-12-31 | $2.30M 20-F · filed 2013-03-04 |